摘要
9-硝基喜树碱(9-NC)为一个半合成喜树碱衍生物,其药理作用主要表现为对拓扑异构酶Ⅰ的抑制。目前,对9-NC的研究已进入Ⅱ期或Ⅲ期临床试验,具有广泛的抗肿瘤活性,且毒性较低,是极具潜力的抗肿瘤新药。现对其药理作用、药动学、临床前研究等作一综述。
9-nitrocamptothecin(9-NC) is a semi-synthetic derivative of camptothecin, acted by inhibition of DNA topoisomerase (Topo Ⅰ). 9-NC is currently in Phase Ⅱ and Ⅲ clinical trials for variety of cancers. This paper presents the pharmacology, pharmacokinetics and pre-clinical studies of 9-NC.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2005年第2期226-230,共5页
Chinese Journal of New Drugs